News
REGENXBIO Inc. announced it will initiate a pivotal phase IIb/III clinical trial for investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in diabetic retinopathy (DR) using suprachoroidal ...
YAG technology, a game-changer for comprehensive range of skin treatments: Our Bureau, Mumbai Friday, August 8, 2025, 14:4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback